A study in humans identified hsa-miR-330-3p as a differentially expressed microRNA that was upregulated in sepsis patients compared to healthy controls [Li et al. DOI:10.1038/s41598-025-89946-6]. A study in human patients with ST-segment elevation myocardial infarction demonstrated that the miR-330-3p was significantly upregulated in plasma from patients with plaque rupture compared to those with plaque erosion [Li et al. DOI:10.1016/j.ygeno.2020.11.019].